secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2026-05-28T20:01:33+00:00
Accession:  0000914475-26-000029
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine annual meeting re-elects three directors, approves equity plan and auditor
--------------------------------------------------------------------------------

- Re-elected Class III directors Kevin C. Gorman, Gary A. Lyons, and Johanna Mercier with over 76M votes each.
- Advisory vote on named executive officer compensation approved: 78.99M for, 5.67M against, 0.10M abstentions.
- Stockholders approved Amended 2025 Equity Incentive Plan: 79.13M for, 5.57M against, 0.07M abstentions.
- Ratified Ernst & Young as independent auditor for FY2026: 83.88M for, 6.17M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447526000029/0000914475-26-000029-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447526000029/nbix-20260527.htm
  HTML page:      https://secwatch.observer/filing/0000914475-26-000029

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer